|
Oct 11
|
Sernova Announces Key New Executive Appointments
|
|
Jun 25
|
Sernova Announces Additional Patient Insulin Independence and Cohort 2 Enrollment Completion in Ongoing Phase I/II Clinical Trial for Treatment of Type 1 Diabetes
|
|
Nov 27
|
Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDA
|
|
Sep 29
|
Sernova Presents Compelling New Data on the Cell Pouch System™ as a Promising Treatment for Post-Operative Hypothyroidism at the 2023 American Thyroid Association Annual Meeting
|